Case File
efta-efta00734410DOJ Data Set 9OtherFrom: Jeffrey M Matusow
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00734410
Pages
3
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey M Matusow
To: Jeffrey Epstein <[email protected]>
Subject: Corn and Wheat
Date: Thu, 12 Aug 2010 14:21:35 +0000
Attachments: JPM_August_USDA_WASDE_Review_2010-08-12_458178.pdf
Inline-Images: ATTOOOO1..jpg
The USDA released updated supply/demand forecasts for the grains this morning.
For corn, higher supplies were offset by increase in demand. We still believe that the supply/demand dynamics are very
tight and susceptible to any supply shocks. Corn is up a point on the news.
On Wheat, we still think that domestic inventories are high enough to cushion the supply disruption from the Russian
drought.
We are buying puts on Wheat to pair with our long Corn exposure. What do you think?
Jeff
Jeffrey M. Matusow
JPMorgan Private Bank 140 West 57th Street, 33rd Floor, New York, NY 10019
Work:
I Fax:
I Email:
IRS Circular 230 Disclosure:
JPMorgan Chase & Co. and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax matters contained herein
(including any attachments) is not intended or written to be used, and cannot be used, in connection with the promotion, marketing
or recommendation by anyone unaffiliated with JPMorgan Chase & Co. of any of the matters addressed herein or for the purpose of
avoiding U.S. tax-related penalties.
Commodities Research
EFTA00734410
August USDA/WASDE Review: A Well Anticipated Report Leaves
Market at Ambiguous Juncture in the Near Term
Click here for the full Note and disclosures.
• The USDA updated US and World balance sheet estimates for major agricultural commodities in the
World Agricultural Supply and Demand Estimates (WASDE) report at 8:30am (Eastern).
• Today's report is important given it presents the first survey-based estimates of new-crop corn and
soybean yield prospects. In the event, upward revisions for both crops were largely in keeping with pre-
report expectations. In the case of com, larger supplies were offset by an increase in export demand; in
light of our belief that yield will ultimately fall below the USDA's current estimate — and the risk that
exports will increase still further — fundamentals remain constructive. The market is not well positioned
to withstand a sub-optimal production outcome.
• The soybean market witnessed similar revisions, with larger domestic yield prospects offsetting
significantly larger export demand. Although 2010/11 US soybean stocks are likely to be more
comfortable than those faced during the currently concluding 2009/10 season, inventories will not reach
formerly bearish estimates, arguing for a more neutral price trajectory.
• Revisions to US and global wheat forecasts were well anticipated; the USDA chose to make relatively
large-scale downward revisions to global production and FSU export forecasts this month, bringing
official estimates in line with private expectations already in the market. US exports saw a large-scale
increase this month in consequence, but it is important to note that domestic inventories remain large
relative to the bullish level witnessed in 2007/08.
Lewis A Hagedorn
(1
JPMorgan Chase Bank NA
If you no longer with to receive these e-mails then click here to unsubscribe
The research analyst(s) denoted by an "AC" on the cover of this report (or, where multiple research analysts are primarily
responsible for this report or sections within, the research analyst(s) denoted by an "AC' on the cover or within the document)
certifies, with respect to each security or issuer that the research analyst covers in this research, that: (1) all of the views expressed
in this report accurately reflect his or her personal views about any and all of the subject securities or issuers; and (2) no part of any
of the research analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views
expressed by the research analyst(s) in this report.
Important disclosures, including price charts, related to the companies recommended in this report are available in the PDF
attachment, through the search function on J.P. Morgan's website
or by calling this
toll free number (1
Confidentiality and Security Notice: This transmission may contain information that is privileged, confidential, legally privileged,
and/or exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any
disclosure, copying, distribution, or use of the information contained herein (including any reliance thereon) is STRICTLY
PROHIBITED. Although this transmission and any attachments are believed to be free of any virus or other defect that might affect
any computer system into which it is received and opened, it is the responsibility of the recipient to ensure that it is virus free and
no responsibility is accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as applicable, for any loss or damage arising
in any way from its use. If you received this transmission in error, please immediately contact the sender and destroy the material in
its entirety, whether in electronic or hard copy format.
EFTA00734411
EFTA00734412
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.